Page last updated: 2024-12-06

n,n-dimethylacrylamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

N,N-Dimethylacrylamide (DMAA) is a colorless liquid monomer used in the synthesis of various polymers. It is a highly reactive compound, prone to polymerization. DMAA is typically synthesized via the reaction of acryloyl chloride with dimethylamine. DMAA is commonly used as a monomer in the production of polyacrylamides, which find applications in water treatment, papermaking, and oil recovery. Due to its excellent film-forming properties and biocompatibility, DMAA is also used in the production of adhesives, coatings, and biomedical materials. DMAA is a versatile monomer with a wide range of applications. The ease of its polymerization and its ability to form strong bonds with other monomers make it a valuable component in various industries. Furthermore, its unique properties make it suitable for use in the production of biodegradable and sustainable materials. Research on DMAA continues to explore its potential in developing new and advanced materials with tailored properties.'

Cross-References

ID SourceID
PubMed CID17587
MeSH IDM0260065

Synonyms (58)

Synonym
dimethylamid kyseliny akrylove [czech]
n,n-dimethyl-2-propenamide
einecs 220-237-5
brn 1742219
ai3-15677
nsc 32613
nsc 35191
acylamide, n,n-dimethyl
n,n-dimethyl-acrylamide
acrylamide, n,n-dimethyl-
2-propenamide, n,n-dimethyl-
acrylamide,n-dimethyl-
2680-03-7
n,n-dimethylacrylamide ,
nsc-32613
nsc32613
2-propenamide,n-dimethyl-
nsc-35191
acylamide,n-dimethyl
nsc35191
n,n-dimethylacrylamide, 99%, contains 500 ppm monomethyl ether hydroquinone as inhibitor
D1091
nn-dimethylacrylamide
inchi=1/c5h9no/c1-4-5(7)6(2)3/h4h,1h2,2-3h3
ylgyacdqvqqzsw-uhfffaoysa-
n,n-dimethylprop-2-enamide
AKOS009157019
as46jk7q6i ,
ec 220-237-5
dimethylamid kyseliny akrylove
unii-as46jk7q6i
dimethylacrylamide, n,n-
AM84856
propenamide, n,n-dimethyl-
n,n-dimethylaminoacrolein
dimethylaminoacrolein
n,n-dimethyl acrylamide
n, n-dimethylacrylamide
dtxcid3030507
tox21_303732
NCGC00357041-01
cas-2680-03-7
dtxsid0051944 ,
J-523265
n,n-dmethylacrylamde
mfcd00008626
n,n-dimethylacrylamide, (stabilized with mehq)
n,n-dimethylacrylamide contains 500 ppm monomethyl ether hydroquinone as inhibitor
D78231
J-016551
?n,n-dimethylacrylamide
n,n-dimethylacrylamide,min. 98%
Q15632705
dmaa; dmac; n,n-dimethyl-2-propenamide
D70136
EN300-189106
CS-0016062
dmaa-n,n

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency27.30600.001530.607315,848.9004AID1224841; AID1259401
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (85)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's7 (8.24)18.2507
2000's33 (38.82)29.6817
2010's38 (44.71)24.3611
2020's7 (8.24)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.58 (24.57)
Research Supply Index4.50 (2.92)
Research Growth Index4.85 (4.65)
Search Engine Demand Index56.46 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (38.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other89 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]